High-Dose Chemotherapy for Adult-Type Ovarian Granulosa Cell Tumors: A Retrospective Study of the European Society for Blood and Marrow Transplantation

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Ugo De GiorgiM Bregni

Abstract

A few small retrospective series reported results with salvage chemotherapy for malignant ovarian adult-type granulosa cell tumors (GCTs), whereas no data are available on high-dose chemotherapy (HDC) with hematopoietic progenitor cell support (HSCS) in these patients. The aim of this study was to analyze the available data of HDC for adult-type GCTs. We conducted a retrospective analysis of ovarian cancer treated with salvage HDC registered with the European Society for Blood and Marrow Transplantation. Of 203 adult female patients with a diagnosis of nonepithelial ovarian cancer treated with salvage HDC with HSCS and registered with the European Society for Blood and Marrow Transplantation, 4 (2%) patients were affected by GCTs. All 4 patients had ovarian adult-type GCTs that relapsed/progressed after first-line chemotherapy. The conditioning regimens included a platinum agent in all 4 patients. Bone marrow recovery was promptly achieved; neither treatment-related deaths or life-threatening toxicities occurred. At a median follow-up of 8.5 months, all patients reported a progressive disease. The patient who underwent multicycle HDC enjoyed a long-term remission of 84 months before progression and is the only one alive after 9...Continue Reading

References

Mar 30, 1999·Gynecologic Oncology·J K WolfD M Gershenson
May 7, 2002·Journal of Pediatric Hematology/oncology·Anat Erdreich-EpsteinJudith G Villablanca
Aug 28, 2003·Bone Marrow Transplantation·P PedrazzoliUNKNOWN European Group for Blood and Marrow Transplantation (EBMT), Solid Tumors Working Party
Sep 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jubilee BrownDavid M Gershenson
Aug 18, 2005·British Journal of Cancer·U De GiorgiUNKNOWN European Group for Blood and Marrow Transplantation Solid Tumours and Paediatric Disease Working Parties
Jul 27, 2007·The New England Journal of Medicine·Lawrence H EinhornRafat Abonour
May 22, 2008·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·P PautierC Lhommé
Oct 25, 2011·Obstetrical & Gynecological Survey·Christine A ParkinsonThankamma V Ajithkumar
Nov 20, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N ColomboUNKNOWN ESMO Guidelines Working Group
Oct 28, 2014·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Saara BrykLeila Unkila-Kallio
Dec 3, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Natraj Reddy AmmakkanavarLawrence H Einhorn
Jul 15, 2015·Journal of Pediatric Hematology/oncology·Martin BeneschChristian Urban

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Ugo De GiorgiM Bregni
Annals of Oncology : Official Journal of the European Society for Medical Oncology
Ugo De GiorgiSolid Tumours Working Party (STWP) of the EBMT
British Journal of Cancer
Ugo De GiorgiEuropean Group for Blood and Marrow Transplantation Solid Tumours and Paediatric Disease Working Parties
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
M LegrosR Plagne
© 2022 Meta ULC. All rights reserved